The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
2
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.EBI
University of Cambridge
11
Recent advances in small molecule and peptide inhibitors of glucose-regulated protein 78 for cancer therapy.EBI
The First Affiliated Hospital of Henan University
34
Discovery and Development of a Selective Inhibitor of the ER Resident Chaperone Grp78.EBI
University of Arizona
2
ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A.EBI
University of Arizona
92
Azabenzimidazole compoundsBDB
Pfizer
31
RORγ modulatorsBDB
Bristol Myers Squibb
33
Phosphonate compounds for treatment of complement mediated disordersBDB
Achillion Pharmaceuticals
3
Triazine Compounds as Antagonists at Bv8-Prokineticin Receptors.BDB
University of Ferrara
38
Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: design, synthesis and biological activity.BDB
Berlex Biosciences